BALPHARMABSEBal Pharma LtdMediumNeutral
Announced Tue, 12 May · 11:27 IST

Intimation on resignation of Company Secretary & Compliance officer.

Kmp ResignedManagement Changes View source PDF

BALPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-8.0%1-day move
₹87.00
prior close
₹83.22
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.1-0.3+0.3-8.0-9.7-7.5-11.0-9.5-2.9+0.1-1.0-9.6
Up moveDown movePending
AI summary

Mr. Abdul Basith, Company Secretary & Compliance Officer and Deputy Nodal Officer of Bal Pharma Limited, has tendered his resignation effective 11th May 2026. He submitted his resignation letter dated 02nd March 2026 citing his decision to pursue opportunities outside the company. The resignation was accepted by the Board on 11th May 2026. As this is a Key Managerial Personnel (KMP) position under the Companies Act 2013, the company will need to appoint a replacement. Until a new Company Secretary is appointed, all secretarial communications should be sent to secretarial@balpharma.com.

Likely market impact

The departure of the Company Secretary creates a temporary gap in compliance and regulatory functions. Shareholders should monitor for announcement of a replacement, as the delay in filling this KMP role could raise governance concerns.